OptimizeRx Q3 EPS $(0.05) Misses $0.09 Estimate, Sales $5M Miss $7.18M Estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.09 by 155.56 percent. This is a 350 percent decrease over earnings of $0.02 per share from the

Benzinga · 11/05/2019 21:04

OptimizeRx (NASDAQ:OPRX) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.09 by 155.56 percent. This is a 350 percent decrease over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $5 million which missed the analyst consensus estimate of $7.18 million by 30.36 percent. This is a 7.66 percent decrease over sales of $5.415 million the same period last year.